Tracy N. Young

University of Colorado Anschutz

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

University of Colorado Anschutz

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

University of Colorado System

Research Subjects

Research Interests

Tracy N. Young has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

Anna E. Krug
Division of Hematology, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado
50 shared publications
Austin E. Gillen
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
50 shared publications
Brett M. Stevens
Division of Hematology, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado
50 shared publications
Craig T. Jordan
Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
50 shared publications
Daniel A. Pollyea
Division of Hematology, University of Colorado School of Medicine, Aurora, CO
50 shared publications
Mohammad Minhajuddin
Division of Hematology, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado
50 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S7 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
PLS-DA loadings from UHPLC/MS-based global metabolomic analysis data of HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S7 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
PLS-DA loadings from UHPLC/MS-based global metabolomic analysis data of HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S12 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Carbon flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 2.5mM 13C6-Glucose for the final 3h.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S12 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Carbon flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 2.5mM 13C6-Glucose for the final 3h.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S13 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Carbon and Nitrogen flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 0.5mM 13C515N2-Glutamine for the final 12h.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S13 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Carbon and Nitrogen flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 0.5mM 13C515N2-Glutamine for the final 12h.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S10 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
PLS-DA loadings from UHPLC/MS-based global metabolomic analysis data of MDS-L cell line treated with DMSO or 100nM OT-82 for 24h.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S10 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
PLS-DA loadings from UHPLC/MS-based global metabolomic analysis data of MDS-L cell line treated with DMSO or 100nM OT-82 for 24h.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S9 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Metabolite abundance obtained from UHPLC/MS-based global metabolomic analysis of MDS-L cell line treated with DMSO or 100nM OT-82 for 24h.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S9 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Metabolite abundance obtained from UHPLC/MS-based global metabolomic analysis of MDS-L cell line treated with DMSO or 100nM OT-82 for 24h.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Joint Pathway Analysis for global metabolomic and proteomic data comparing differentially expressed metabolites and protein in HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S8 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Joint Pathway Analysis for global metabolomic and proteomic data comparing differentially expressed metabolites and protein in HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Metabolite abundance obtained from UHPLC/MS-based global metabolomic analysis of HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S6 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Metabolite abundance obtained from UHPLC/MS-based global metabolomic analysis of HR-MDS (N=7) and healthy control (N=7) CD34+ HSPCs.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S14 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Nitrogen flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 2mM 15N2-Tryptophan for the full 24h.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S14 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Nitrogen flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 2mM 15N2-Tryptophan for the full 24h.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Protein Enrichment Analysis for LC/MS-based global proteomic analysis data comparing differentially expressed protein in HR-MDS (N=7) versus healthy control (N=7) CD34+ HSPCs.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Protein Enrichment Analysis for LC/MS-based global proteomic analysis data comparing differentially expressed protein in HR-MDS (N=7) versus healthy control (N=7) CD34+ HSPCs.
Open Access
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Geneset Enrichment Analysis for microarray data (GSE19429) comparing differentially expressed genes in HR-MDS (N=183) versus healthy control (N=17) CD34+ HSPCs.
Website
Google Scholar
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Table S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
by Sweta B. Patel, Daniel R. Moskop, Steven Moreira, Stephanie Gipson, Colin C. Anderson, Alexandra Crook, Maxwell McCabe, Daniel Stephenson, Hannah E. Terry, Andrew Kent, et al.
Geneset Enrichment Analysis for microarray data (GSE19429) comparing differentially expressed genes in HR-MDS (N=183) versus healthy control (N=17) CD34+ HSPCs.

Show all